Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-21-006828
Filing Date
2021-11-04
Accepted
2021-11-04 16:03:05
Documents
2
Period of Report
2021-10-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 12113
2 NOLTE POA noltepoa.htm EX-24 2542
  Complete submission text file 0001562180-21-006828.txt   16062
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Issuer) CIK: 0001395937 (see all company filings)

EIN.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address
Nolte Alexander (Reporting) CIK: 0001891979 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37708 | Film No.: 211379835